Background: Vascular calcification is a common feature in patients with chronic kidney disease ( CKD ). CKD increases serum levels of tumor necrosis factor‐α (TNFα), a critical mediator of vascular calcification. However, the molecular mechanism by which TNF α promotes CKD ‐dependent vascular calcification remains obscure. The purpose of the present study was to investigate whether TNF α‐induced vascular calcification in CKD is caused by the endoplasmic reticulum response involving protein kinase RNA ‐like endoplasmic reticulum kinase ( PERK ), eukaryotic initiation factor 2α (eIF2α), activating transcription factor 4 ( ATF 4), and C/ EBP homologous protein ( CHOP ). Methods and Results: We examined the effects of TNF α on the endoplasmic reticulum ( ER ) stress response of vascular smooth muscle cells ( VSMC s). TNF α treatment drastically induced the PERK ‐eIF2α‐ ATF 4‐ CHOP axis of the ER stress response in VSMC s. PERK , ATF 4, and CHOP sh RNA ‐mediated knockdowns drastically inhibited mineralization and osteogenesis of VSMC s induced by TNF α. CKD induced by 5/6 nephrectomies activated the PERK ‐eIF2α‐ ATF 4‐ CHOP axis of the ER stress response in the aortas of ApoE −/− mice with increased aortic TNF α expression and vascular calcification. Treatment of 5/6 nephrectomized ApoE −/− mice with the TNF α neutralizing antibody or chemical Chaperones reduced aortic PERK ‐eIF2α‐ ATF 4‐ CHOP signaling of the ER stress increased by CKD . This resulted in the inhibition of CKD ‐dependent vascular calcification. Conclusions: These results suggest that TNF α induces the PERK ‐eIF2α‐ ATF 4‐ CHOP axis of the ER stress response, leading to CKD ‐dependent vascular calcification.
Bile acid signaling is a critical regulator of glucose and energy metabolism, mainly through the nuclear receptor FXR and the G protein-coupled receptor TGR. The purpose of the present study was to investigate whether dual activation of FXR and TGR5 plays a significant role in the prevention of atherosclerosis progression. To evaluate the effects of bile acid signaling in atherogenesis, ApoE−/− mice and LDLR−/− mice were treated with an FXR/TGR5 dual agonist (INT-767). INT-767 treatment drastically reduced serum cholesterol levels. INT-767 treatment significantly reduced atherosclerotic plaque formation in both ApoE−/− and LDLR−/− mice. INT-767 decreased the expression of pro-inflammatory cytokines and chemokines in the aortas of ApoE−/− mice through the inactivation of NF-κB. In addition, J774 macrophages treated with INT-767 had significantly lower levels of active NF-κB, resulting in cytokine production in response to LPS through a PKA dependent mechanism. This study demonstrates that concurrent activation of FXR and TGR5 attenuates atherosclerosis by reducing both circulating lipids and inflammation.
Fibroblast growth factor 21 (FGF21) has recently emerged as a metabolic hormone involved in regulating glucose and lipid metabolism in mouse, but the regulatory mechanisms and actions of FGF21 in humans remain unclear. Here we have investigated the regulatory mechanisms of the human FGF21 gene at the transcriptional level. A deletion study of the human FGF21 promoter (−1672 to +230 bp) revealed two fasting signals, including peroxisome proliferator-activated receptor α (PPARα) and glucagon signals, that independently induced human FGF21 gene transcription in mouse primary hepatocytes. In addition, two feeding signals, glucose and xylitol, also dose-dependently induced human FGF21 gene transcription and mRNA expression in both human HepG2 cells and mouse primary hepatocytes. FGF21 protein expression and secretion were also induced by high glucose stimulation. The human FGF21 promoter (−1672 to +230 bp) was found to have a carbohydrate-responsive element at −380 to −366 bp, which is distinct from the PPAR response element (PPRE). Knock-down of the carbohydrate response element binding protein by RNAi diminished glucose-induced human FGF21 transcription. Moreover, we found that a region from −555 to −443 bp of the human FGF21 promoter region exerts an important role in the activation of basic transcription. In conclusion, human FGF21 gene expression is paradoxically and independently regulated by both fasting and feeding signals. These regulatory mechanisms suggest that human FGF21 is increased with nutritional crisis, including starvation and overfeeding.
26 October 2015 in Journal of Clinical Investigation
Recent evidence indicates that saturated fatty acid–induced (SFA-induced) lipotoxicity contributes to the pathogenesis of cardiovascular and metabolic diseases; however, the molecular mechanisms that underlie SFA-induced lipotoxicity remain unclear. Here, we have shown that repression of stearoyl-CoA desaturase (SCD) enzymes, which regulate the intracellular balance of SFAs and unsaturated FAs, and the subsequent accumulation of SFAs in vascular smooth muscle cells (VSMCs), are characteristic events in the development of vascular calcification. We evaluated whether SMC-specific inhibition of SCD and the resulting SFA accumulation plays a causative role in the pathogenesis of vascular calcification and generated mice with SMC-specific deletion of both Scd1 and Scd2. Mice lacking both SCD1 and SCD2 in SMCs displayed severe vascular calcification with increased ER stress. Moreover, we employed shRNA library screening and radiolabeling approaches, as well as in vitro and in vivo lipidomic analysis, and determined that fully saturated phosphatidic acids such as 1,2-distearoyl-PA (18:0/18:0-PA) mediate SFA-induced lipotoxicity and vascular calcification. Together, these results identify a key lipogenic pathway in SMCs that mediates vascular calcification.
21 April 2022 in The Journal of Nutritional Biochemistry